Want to find Targeted B2B leads? Slice and dice from over 84 million business prospects across 675+ industries, 400+ technologies, ad spend, and much more. Try it now for FREE!

How it works video / FAQ




Industries: Startups

Technologies: rxipharma.com is using 5 Technologies.

Employees: We found 0 verified contacts and 10 unverified employees.

Social Media: rxipharma.com has 24 social media shares and likes.

We have 2 emails for rxipharma.com.

Analytics Technology

Google Analytics
Google Analytics shows you the full customer picture across ads and videos, websites and social tools, tablets and smartphones. That makes it easier to serve your current customers and win new ones.

Social Media

CMS Technology

WordPress.com allows you to create a free website or make a blog using hundreds of customizable themes

Web Server Technology

The Apache HTTP Server Project is an initiative to develop and maintain an open-source HTTP server for operating systems such as UNIX and Windows NT.

Frameworks Technology

PHP is a popular general-purpose scripting language that works well for web development.

Javascript Technology

jQuery is a fast, small, and feature-rich JavaScript library. It makes things like HTML document traversal and manipulation, event handling, animation, and Ajax much simpler with an easy-to-use API that works across a multitude of browsers. With a combination of versatility and extensibility, jQuery has changed the way that millions of people write JavaScript.

Unverified Contacts

These are contacts we've discovered through publicly available sources and might be outdated.
Use our PerfectLink™ Contact Finder to verify contacts.

Dmitry Samarsky Ph.D.
Vice President - Technology and Business Devel
Sanford Hillsberg
Chairman of the Board
Konstantinos Andrikopoulos
Vice President, Legal Counsel, Chief Intellectual Property Counsel
Tod Woolf Ph.D.
President, CEO, Director
Joanne Kamens
Director Discovery
Donna Falcetti
Director of Operations
Karen Bulock
VP Research
Lyn Libertine
VP Medical Affairs/Safety Assessment
Geert Cauwenbergh
Robert Bitterman

Additional Info and Employees

RXi Pharmaceuticals develops therapeutics based on ribonucleic acid interference.


Noah D. Beerman
President and CEO at RXi Pharmaceuticals

Pamela J. Pavco
Chief Development Officer at RXi Pharmaceuticals

Robert J. Bitterman
Director at RXi Pharmaceuticals

rxipharma.com Emails

Sign up to get full access to all the rxipharma.com emails we have.


Find emails for rxipharma.com executives, including the Chief Executive Officer, Chief Financial Officer, and Chief Marketing Officer.